NCN is most concerned about the Series A hurdle for startups in the Nashville area.
Spying opportunity to speed adoption of evidence-based medicine, startup asserts itself.
Here's an update on salient capital raises and related.
[updated] Startup greenlighted with patient capital, golden Roladexes.
Initially targeting health systems, startup is advised by Harpeth Capital.
Steve Case, Jim Lackey, Sal Novin, Marc Guthrie, PE gig -- and the late Dave Chapman.
[updated New CEO named] With sector veterans on its board and access to capital, this startup girds for raise.
Four business leaders formed the core of group that picked the NEC's inaugural board
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: